The Voluntary Scheme for Branded Medicines Pricing and Access in the UK is now presenting from senior industry executives in a recent article in 𝘛𝘩𝘦 𝘗𝘩𝘢𝘳𝘮𝘢𝘤𝘦𝘶𝘵𝘪𝘤𝘢𝘭 𝘑𝘰𝘶𝘳𝘯𝘢𝘭. Comments along the lines of “Why would you …

Belgium’s drug reimbursement system has become increasingly lengthy and complex, compromising patient access to innovative medicines. The roadmap recently presented by the Minister of Health and the Belgian National Institute for Health and …

First approval in Europe for lurbinectedin. PharmaMar (MSE:PHM) has announced today that it has received the Temporary Authorisation for the commercialization of Zepzelca® (lurbinectedin) by the Swiss Agency for Therapeutic Products (Swissmedic) for …

The Ministry of Health reaches a “consensus” with the communities to expand the FSE. The Minister of Health, Carolina Darias, has announced that a “consensus” has been reached with the autonomous communities for the deployment …

France is the first country in the European Union to establish a long-term framework for the reimbursement by Health Insurance of medical remote monitoring providing a clinical benefit or improving the organization of …

On March 17, 2023, the French National Authority for Health (HAS) published an update on its recommendations for techniques to be used within the organized breast cancer screening. HAS recommends introducing mammography …

The objective of the European taskforce is to reach a mutual understanding between competent agencies with competences in health technology assessment for digital medical devices (DMDs) at national level, in order to …

Let’s hope it’s the end of Maverick CEOs in the NHS. NHS England is offering extra revenue funding to systems that agree to hold their financial positions for 2022-23 at an agreed …